• Partners
  • Patents
  • Blog
  • White Papers
  • xMAP® Insights Magazine
    • xMAP® Insights 2022 Issue
    • xMAP® Insights 2021 Issue 2
    • xMAP® Insights 2021 Issue 1
    • xMAP® Insights 2020 Issue
    • xMAP® Insights 2019 Issue
    • xMAP® Insights 2018 Issue
    • xMAP® Insights 2017 Issue 2
    • xMAP® Insights 2017 Issue 1
    • xMAP® Insights 2016 Issue
  • Cancer
  • Video Pages
    • xMAP® Technology Videos
    • VERIGENE® System Videos
    • Luminex® 100/200 Videos
  • Terms & Policies
    • Reagent Shipping Policy
    • Terms & Conditions of Sale United States
    • Terms & Conditions of Sale International
  • Menu Menu

LIAISON PLEX®

Respiratory Flex (RSP Flex) Assay

Viral Targets

Bacterial Targets

Tier 1

0 Targets / 0 Credits

Tier 2

0 Targets / 5 Credits

Tier 3

0 Targets / 5 Credits

0

CREDITS

Email Address This field is required. Get my panel!
Scroll to top

Follow us

Group

  • Company
  • Sustainability
  • Investors
  • Careers
  • Newsroom

Our Solutions

  • Immunodiagnostics
  • Molecular Diagnostics
  • Luminex LTG

Useful Links

  • Contact us
  • Diasorin worldwide
  • Immuno products Catalog
  • My Luminex

Legal Information

  • Legal notice
  • Privacy policy
  • Modern slavery statement
  • Accessibility

Document Repository

Diasorin Immuno and Molecular product documentation

Dialog

Licensed Technologies and Luminex products

Product documentation

DiaSorin S.p.A. - Share Capital €55.948.257 R.E.A. 180729 - Fiscal Code and Subscription to Vercelli Companies Register no 13144290155